Hepatitis B: Resistência a Análogos Núcleos(t)idos Hepatitis B: Resistência a Análogos Núcleos(t)idos Hepatitis B: Resistência a Análogos Núcleos(t)idos Hepatitis B: Resistência a Análogos Núcleos(t)idos Hepatitis B: Resistência a Análogos Núcleos(t)idos Hepatitis B: Resistance to Nucleosideos Analogues
作者： Hugo Fainboim , Silvia Paz
DOI:
关键词: Virus 、 Lamivudine 、 Hepatitis B 、 Emtricitabina 、 Adefovir 、 Tenofovir 、 Entecavir 、 Virology 、 Medicine 、 Interferon
摘要: A infeccao pelo virus B e um importante problema de saude publica. E a causa mais frequente cirrose hepatocarcinoma no mundo. As drogas utilizadas tratamento da hepatite cronica (HBV) sao : Interferon peguilado (IFN-PEG), lamivudina (LMV), adefovir dipivoxil (ADV) entecavir (ETV). Outras se encontram em investigacao:telbivudina (LdT), emtricitabina (FTC), tenofovir (TDF) clevudina (CVD). resistencia ao comun com os analogos nucleotideos, sendo principal dstes. O estudo novas combinacoes fundamental para evitar esta atingir erradiccao viral. Palavras-chave: B, viral, lamivudina. The infection is un important health problem. It the most frequent cause of cirrhosis and celular in world. used drugs for treating hepatitis ar: peguilated interferon, lamivudine, entecavir. Others are still investigation phase. resistance common with lamivudine. New therapy combination essential avoiding this resistency obtaining viral clearance.
参考文章(10)
Huiling Yang, Xiaoping Qi, Alex Sabogal, Michael Miller, Shelly Xiong, William E Delaney IV, None, Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antiviral Therapy. ,vol. 10, pp. 625- 633 ,(2005)
Fabien Zoulim, Stephen Locarnini, Emmet B. Keeffe, Jenny Heathcote, T. Jake Liang, David Mutimer, Jean Michel Pawlotsky, Angelas Hatzakis, Management of antiviral resistance in patients with chronic hepatitis B. Antiviral Therapy. ,vol. 9, pp. 679- 693 ,(2004)
Tim Shaw, Angeline Bartholomeusz, Stephen Locarnini, HBV drug resistance: Mechanisms, detection and interpretation Journal of Hepatology. ,vol. 44, pp. 593- 606 ,(2006) , 10.1016/J.JHEP.2006.01.001
Peter Angus, Rhys Vaughan, Shelly Xiong, Huiling Yang, William Delaney, Craig Gibbs, Carol Brosgart, Danielle Colledge, Rosalind Edwards, Anna Ayres, Angeline Bartholomeusz, Stephen Locarnini, Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Gastroenterology. ,vol. 125, pp. 292- 297 ,(2003) , 10.1016/S0016-5085(03)00939-9
Man-Fung Yuen, Erwin Sablon, Chee-Kin Hui, He-Jun Yuan, Hilde Decraemer, Ching-Lung Lai, Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology. ,vol. 34, pp. 785- 791 ,(2001) , 10.1053/JHEP.2001.27563
K. Borroto-Esoda, S. Arterburn, A. Snow, S. Chuck, S. Hadziyannis, S. Locamini, E. Zoulim, J.-M. Pawlotsky, 483 Final analysis of virological outcomes and resistance during 5 years of adefovir dipivoxil monotherapy in HBeAg-negative patients Journal of Hepatology. ,vol. 44, ,(2006) , 10.1016/S0168-8278(06)80483-6
Oliver Schildgen, Hueseyin Sirma, Anneke Funk, Cynthia Olotu, Ulrike C. Wend, Heinz Hartmann, Martin Helm, Jürgen K. Rockstroh, Wulf R. Willems, Hans Will, Wolfram H. Gerlich, Variant of hepatitis B virus with primary resistance to adefovir The New England Journal of Medicine. ,vol. 354, pp. 1807- 1812 ,(2006) , 10.1056/NEJMOA051214
Anna SF Lok, Ching-Lung Lai, Nancy Leung, Guang-Bi Yao, Zhen-Yu Cui, Eugene R Schiff, Jules L Dienstag, E Jenny Heathcote, Nancy R Little, Dorothea A Griffiths, Stephen D Gardner, Mary Castiglia, None, Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology. ,vol. 125, pp. 1714- 1722 ,(2003) , 10.1053/J.GASTRO.2003.09.033
William M. Lee, Hepatitis B Virus Infection New England Journal of Medicine. ,vol. 337, pp. 1733- 1745 ,(1997) , 10.1056/NEJM199712113372406
Morris Sherman, Cihan Yurdaydin, Jose Sollano, Marcelo Silva, Yun–Fan Liaw, Janusz Cianciara, Anna Boron–Kaczmarska, Paul Martin, Zachary Goodman, Richard Colonno, Anne Cross, Gail Denisky, Bruce Kreter, Robert Hindes, AI463026 BEHoLD Study Group, Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology. ,vol. 130, pp. 2039- 2049 ,(2006) , 10.1053/J.GASTRO.2006.04.007